Gene · 7030
Papers3,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
A report of thirteen non-conventional FLCN-mutated (renal) tumors (FMT) and a discussion of proposed diagnostic criteria, convergent FLCN/TFEB and FLCN/MITF E318K signaling, and FLCN immunohistochemistry. | Hum Pathol | 2026 | 42315013 | PubTator, text mining | PubMed |
| Autophagic flux blockade under hypocapnia reveals CO2-sensitive regulation of autophagy-lysosome homeostasis. | Biol Open | 2026 | 42299070 | PubTator, text mining | PubMed |
| VPS13C-mediated endoplasmic reticulum-lysosome tethering in neuronal stress responses. | Tissue Cell | 2026 | 42284733 | PubTator, text mining | PubMed |
| Dynorphin B Promotes Autophagy and Cytotoxicity in Thyroid Cancer Cells via the mTORC1-TFE3 Axis. | J Biochem Mol Toxicol | 2026 | 42262709 | PubTator, text mining | PubMed |
| ASPSCR1::TFE3-rearranged renal cell carcinomas: clinicopathologic, molecular, and survival analysis of 30 cases. | Virchows Arch | 2026 | 42259998 | PubTator, text mining | PubMed |
| A Case of Acalculous Cholecystitis During Lenvatinib Plus Pembrolizumab Therapy for Advanced Renal Cell Carcinoma. | IJU Case Rep | 2026 | 42256328 | PubTator, text mining | PubMed |
| Belzutifan for Metastatic TFE3-Rearranged Renal Cell Carcinoma With Pulmonary Metastases: A Case Report. | IJU Case Rep | 2026 | 42256325 | PubTator, text mining | PubMed |
| Micronodular PEComa of the appendix: a case report. | Front Med (Lausanne) | 2026 | 42254402 | PubTator, text mining | PubMed |
| Epithelioid Angiomyolipoma Masquerading as Renal Cell Carcinoma: A Case Report. | Cureus | 2026 | 42238154 | PubTator, text mining | PubMed |
| Papillary-Predominant FLCN-Mutated Renal Epithelial Neoplasm in Birt-Hogg-Dubé Syndrome. | Int J Surg Pathol | 2026 | 42231833 | PubTator, text mining | PubMed |
| A hypervascular perivascular epithelioid cell tumor of the urinary bladder showing TFE3 immunoreactivity clinically misdiagnosed as paraganglioma in an adolescent patient. | BMC Urol | 2026 | 42231283 | PubTator, text mining | PubMed |
| Clinical Outcomes and Therapeutic Response in Adult TFE3-Related Renal Cell Carcinoma: A Case Series From a Tertiary Cancer Center in Southern India. | Cureus | 2026 | 42220779 | PubTator, text mining | PubMed |
| Integrated Molecular, Genomic, and Clinical Characterization of Pediatric and Adolescent Translocation Renal Cell Carcinoma: A Report from the Children's Oncology Group. | Biomedicines | 2026 | 42193282 | PubTator, text mining | PubMed |
| FGF21 rejuvenates aged human adipose-derived mesenchymal stem cells via enhancement of TFE3-mediated autophagy flux. | Autophagy | 2026 | 42157427 | PubTator, text mining | PubMed |
| Perivascular Epithelioid Cell Tumors: Pathogenesis, Clinical Features, and Radiologic Challenges. | Radiographics | 2026 | 42126968 | PubTator, text mining | PubMed |
| Rethinking Advanced Renal Cell Carcinoma: Integrative Genomics, Immunotherapy, and Molecular-Orthomolecular Strategies. | Cancers (Basel) | 2026 | 42122230 | PubTator, text mining | PubMed |
Comprehensive analysis of six MED15::TFE3 renal cell carcinomas including two novel solid MED15::TFE3 renal cell carcinomas, highlighting their morphologic, immunohistochemical and molecular differences from their cystic counterparts. | Virchows Arch | 2026 | 42113263 | PubTator, text mining | PubMed |
| NF2-mutated Renal Cell Carcinoma: Clinicopathologic and Molecular Characterization of Two Additional Tumors Highlighting Morphologic Heterogeneity and Potential Aggressive Behavior. | Int J Surg Pathol | 2026 | 42087751 | PubTator, text mining | PubMed |
| Retroperitoneal Schwannoma with a Novel PRCC::TFE3 Fusion: Expanding the Spectrum of Schwannomas with a TFE3 Gene Rearrangement. | Int J Surg Pathol | 2026 | 42087746 | PubTator, text mining | PubMed |
| TFE3-rearranged renal cell carcinoma - Morphology and differential diagnosis. | Urol Case Rep | 2026 | 42064255 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7030/papers?page=3